Tag: Amgen

8/16/2017

Investors aren’t the only ones burned by misleading drug company news releases

1 3/20/2017

No surprise: Repatha reality is messier than initial reports suggested

2/9/2017

Tainted at the source: Misleading PR claims that flow downstream to health news consumers

11/7/2012

Pumping out heart news from the big Heart Association conference

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

View More

Categories

View More

Tags

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

NY Times hails MitraClip a ‘huge advance’ for heart failure, but independent sources might have said otherwise https://t.co/cdD1hAtARd

Reply on TwitterRetweet on Twitter4Like on Twitter6Twitter
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

NY Times hails MitraClip a ‘huge advance’ for heart failure, but independent sources might have said otherwise https://t.co/cdD1hAtARd

Reply on TwitterRetweet on Twitter4Like on Twitter6Twitter
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Time to test all infants’ gut microbiomes — or is this a product in search of a condition?
https://t.co/zXdv2Vfn1y

Reply on TwitterRetweet on Twitter3Like on TwitterTwitter